期刊
INTERNATIONAL JOURNAL OF NANOMEDICINE
卷 13, 期 -, 页码 1899-1915出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/IJN.S156528
关键词
CARPA; cross-linking; irritation potential; MRI; SPION; storage stability
资金
- EU project NanoAthero [FP7-NMP-2012-LARGE-6-309820]
- Deutsche Forschungsgemeinschaft (German Research Foundation) [CI 162/2-1, CI 162/2-3, AL552/8-1]
- FUMIN Bridge Funding appropriations
- Bavarian State Ministry of the Environment and Consumer Protection
- Deutsche Forschungsgemeinschaft
- Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Background: Rising criticism of currently available contrast agents for magnetic resonance imaging, either due to their side effects or limited possibilities in terms of functional imaging, evoked the need for safer and more versatile agents. We previously demonstrated the suitability of novel dextran-coated superparamagnetic iron oxide nanoparticles (SPIONDex) for biomedical applications in terms of safety and biocompatibility. Methods: In the present study, we investigated the size-dependent cross-linking process of these particles as well as the size dependency of their imaging properties. For the latter purpose, we adopted a simple and easy-to-perform experiment to estimate the relaxivity of the particles. Furthermore, we performed an extensive analysis of the particles' storage stability under different temperature conditions, showing their superb stability and the lack of any signs of agglomeration or sedimentation during a 12 week period. Results: Independent of their size, SPIONDex displayed no irritation potential in a chick chorioallantoic membrane assay. Cell uptake studies of ultra-small (30 nm) SPIONDex confirmed their internalization by macrophages, but not by non-phagocytic cells. Additionally, complement activation-related pseudoallergy (CARPA) experiments in pigs treated with ultra-small SPIONDex indicated the absence of hypersensitivity reactions. Conclusion: These results emphasize the exceptional safety of SPIONDex, setting them apart from the existing SPION-based contrast agents and making them a very promising candidate for further clinical development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据